IL-32 monoclonal antibodies and uses thereof
US7641904B2 · kind B2 · utility
4Cited by
11References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 15, 2008 |
| Grant date | Jan 5, 2010 |
| Priority date | — |
| Expiry date | Feb 15, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/809
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides monoclonal antibodies specific for interleukin-32 (IL-32, previously referred to as “natural killer cell transcript 4” or “NK4”) and hybridomas secreting monoclonal antibodies specific for IL-32. Also provided are diagnostic methods and kits (e.g., ELISA, Western blot, etc.) which utilize monoclonal antibodies specific for IL-32.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.